Les Lieberman, FCB Financial Holdings, Inc. (FCB)’s insider Sold 147,159 Shares; Last Week Arcadia Biosciences, Inc. (RKDA) Coverage

Among 2 analysts covering Arcadia Biosciences (NASDAQ:RKDA), 0 have Buy rating, 0 Sell and 2 Hold. Therefore 0 are positive. Arcadia Biosciences had 2 analyst reports since May 12, 2017 according to SRatingsIntel. Piper Jaffray maintained Arcadia Biosciences, Inc. (NASDAQ:RKDA) rating on Friday, July 21. Piper Jaffray has “Hold” rating and $100 target. The company was downgraded on Friday, May 12 by PiperJaffray. See Arcadia Biosciences, Inc. (NASDAQ:RKDA) latest ratings:

Les Lieberman, Executive Vice Chairman of Fcb Financial Holdings Inc, in an insider legal trade unloaded some 147,159 shares whose sum is estimated to be $8,424,853 at average stock price of $57.3. At present, Les Lieberman owns 565,292 shares which are equivalent to around 1.26% of Fcb Financial Holdings Inc’s market capitalization (total value of the shares outstanding).

Since September 11, 2017, it had 0 buys, and 46 selling transactions for $38.48 million activity. Ellert Kent S sold $1.78 million worth of stock or 32,301 shares. Another trade for 11,141 shares valued at $494,605 was sold by ORAN STUART I. Lieberman Les J had sold 3,802 shares worth $183,524 on Tuesday, October 3. SALERNO FREDERIC V sold $1.02 million worth of FCB Financial Holdings, Inc. (NYSE:FCB) on Tuesday, January 2. 25,615 shares valued at $1.22 million were sold by TESE VINCENT on Wednesday, September 27. The insider BERNIKOW ALAN S sold 44,130 shares worth $2.16 million. $1.08M worth of FCB Financial Holdings, Inc. (NYSE:FCB) was sold by NOVELLY PAUL A.

FCB Financial Holdings, Inc. operates as the bank holding firm for Florida Community Bank, N.A. that provides various financial services and products to individuals, small and medium-sized businesses, large businesses, and other local organizations and entities in south and central Florida. The company has market cap of $2.54 billion. The firm offers various deposit products, including demand deposit accounts, interest-bearing products, savings accounts, and certificates of deposit; checking products; and money market accounts and IRAs. It has a 20.92 P/E ratio. It also offers consumer loans, such as personal and auto loans, recreational loans, and home improvement/second mortgage loans.

Among 11 analysts covering FCB Financial Holdings (NYSE:FCB), 5 have Buy rating, 0 Sell and 6 Hold. Therefore 45% are positive. FCB Financial Holdings has $65 highest and $36 lowest target. $50.56’s average target is -10.83% below currents $56.7 stock price. FCB Financial Holdings had 22 analyst reports since July 22, 2015 according to SRatingsIntel. The rating was downgraded by Hovde Group on Monday, November 14 to “Market Perform”. The company was initiated on Thursday, January 7 by Gabelli. The rating was maintained by Hovde Group with “Hold” on Monday, February 5. The firm earned “Hold” rating on Monday, February 26 by Keefe Bruyette & Woods. The stock of FCB Financial Holdings, Inc. (NYSE:FCB) has “Buy” rating given on Wednesday, October 25 by RBC Capital Markets. RBC Capital Markets maintained FCB Financial Holdings, Inc. (NYSE:FCB) on Thursday, September 7 with “Buy” rating. The firm earned “Buy” rating on Wednesday, January 24 by Bank of America. On Wednesday, July 26 the stock rating was maintained by RBC Capital Markets with “Buy”. UBS downgraded FCB Financial Holdings, Inc. (NYSE:FCB) rating on Wednesday, January 11. UBS has “Neutral” rating and $52 target. On Wednesday, January 24 the stock rating was maintained by RBC Capital Markets with “Buy”.

The stock decreased 0.87% or $0.5 during the last trading session, reaching $56.7. About 276,098 shares traded or 28.53% up from the average. FCB Financial Holdings, Inc. (NYSE:FCB) has risen 30.63% since March 12, 2017 and is uptrending. It has outperformed by 13.93% the S&P500.

Analysts await FCB Financial Holdings, Inc. (NYSE:FCB) to report earnings on April, 19. They expect $0.84 earnings per share, up 31.25% or $0.20 from last year’s $0.64 per share. FCB’s profit will be $37.57 million for 16.88 P/E if the $0.84 EPS becomes a reality. After $0.76 actual earnings per share reported by FCB Financial Holdings, Inc. for the previous quarter, Wall Street now forecasts 10.53% EPS growth.

Investors sentiment decreased to 1.19 in Q3 2017. Its down 0.36, from 1.55 in 2017Q2. It fall, as 21 investors sold FCB Financial Holdings, Inc. shares while 41 reduced holdings. 25 funds opened positions while 71 raised stakes. 40.82 million shares or 1.34% more from 40.28 million shares in 2017Q2 were reported. Piermont Cap Management holds 46,064 shares. Manufacturers Life The holds 0.04% or 779,213 shares in its portfolio. Bartlett And Limited Liability holds 4,152 shares or 0.01% of its portfolio. Legal & General Gp Public Ltd Liability Com holds 0% of its portfolio in FCB Financial Holdings, Inc. (NYSE:FCB) for 17,912 shares. Moreover, Westfield Management Lp has 0.24% invested in FCB Financial Holdings, Inc. (NYSE:FCB) for 642,600 shares. Alpine Woods Cap Ltd Liability Corporation owns 12,000 shares. Citadel Advsrs owns 627,141 shares or 0.02% of their US portfolio. Dimensional Fund Lp reported 1.46M shares. Goldman Sachs reported 153,909 shares stake. First Tru Advisors L P accumulated 72,480 shares. Ubs Asset Mgmt Americas owns 0% invested in FCB Financial Holdings, Inc. (NYSE:FCB) for 23,079 shares. North Carolina-based Sterling Management Ltd Liability has invested 0.01% in FCB Financial Holdings, Inc. (NYSE:FCB). First Personal, North Carolina-based fund reported 232 shares. Kennedy Capital Management reported 132,600 shares or 0.12% of all its holdings. North Carolina-based Natl Bank Of America De has invested 0% in FCB Financial Holdings, Inc. (NYSE:FCB).

The stock increased 23.08% or $2.4 during the last trading session, reaching $12.8. About 3.53 million shares traded or 3990.37% up from the average. Arcadia Biosciences, Inc. (NASDAQ:RKDA) has declined 43.32% since March 12, 2017 and is downtrending. It has underperformed by 60.02% the S&P500.